1
|
Tirandi A, Sgura C, Carbone F, Montecucco F, Liberale L. Inflammatory biomarkers of ischemic stroke. Intern Emerg Med 2023; 18:723-732. [PMID: 36745280 PMCID: PMC10082112 DOI: 10.1007/s11739-023-03201-2] [Citation(s) in RCA: 24] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/31/2022] [Accepted: 01/09/2023] [Indexed: 02/07/2023]
Abstract
Ischemic stroke remains the second leading cause of death and among the major causes of morbidity worldwide. Therapeutic options are currently limited to early reperfusion strategies, while pharmacological neuroprotective strategies despite showing promising results in the experimental setting constantly failed to enter the clinical arena. Inflammation plays an important role in the pathophysiology of ischemic stroke and mediators of inflammation have been longtime investigated as possible prognostic marker and therapeutic target for stroke patients. Here, we summarized available evidence on the role of cytokines, soluble adhesion molecules and adipokines in the pathophysiology, prognosis and therapy of ischemic stroke.
Collapse
Affiliation(s)
- Amedeo Tirandi
- Department of Internal Medicine, University of Genoa, Viale Benedetto XV, 6, 16132, Genoa, Italy
| | - Cosimo Sgura
- Department of Internal Medicine, University of Genoa, Viale Benedetto XV, 6, 16132, Genoa, Italy
| | - Federico Carbone
- Department of Internal Medicine, University of Genoa, Viale Benedetto XV, 6, 16132, Genoa, Italy
- IRCCS Ospedale Policlinico San Martino Genoa, Italian Cardiovascular Network, Largo Rosanna Benzi 10, 16132, Genoa, Italy
| | - Fabrizio Montecucco
- Department of Internal Medicine, University of Genoa, Viale Benedetto XV, 6, 16132, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino Genoa, Italian Cardiovascular Network, Largo Rosanna Benzi 10, 16132, Genoa, Italy.
| | - Luca Liberale
- Department of Internal Medicine, University of Genoa, Viale Benedetto XV, 6, 16132, Genoa, Italy
- IRCCS Ospedale Policlinico San Martino Genoa, Italian Cardiovascular Network, Largo Rosanna Benzi 10, 16132, Genoa, Italy
| |
Collapse
|
2
|
Munji RN, Soung AL, Weiner GA, Sohet F, Semple BD, Trivedi A, Gimlin K, Kotoda M, Korai M, Aydin S, Batugal A, Cabangcala AC, Schupp PG, Oldham MC, Hashimoto T, Noble-Haeusslein LJ, Daneman R. Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood-brain barrier dysfunction module. Nat Neurosci 2019; 22:1892-1902. [PMID: 31611708 PMCID: PMC6858546 DOI: 10.1038/s41593-019-0497-x] [Citation(s) in RCA: 208] [Impact Index Per Article: 34.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Accepted: 08/13/2019] [Indexed: 01/08/2023]
Abstract
Blood vessels in the CNS form a specialized and critical structure, the blood-brain barrier (BBB). We present a resource to understand the molecular mechanisms that regulate BBB function in health and dysfunction during disease. Using endothelial cell enrichment and RNA sequencing, we analyzed the gene expression of endothelial cells in mice, comparing brain endothelial cells with peripheral endothelial cells. We also assessed the regulation of CNS endothelial gene expression in models of stroke, multiple sclerosis, traumatic brain injury and seizure, each having profound BBB disruption. We found that although each is caused by a distinct trigger, they exhibit strikingly similar endothelial gene expression changes during BBB disruption, comprising a core BBB dysfunction module that shifts the CNS endothelial cells into a peripheral endothelial cell-like state. The identification of a common pathway for BBB dysfunction suggests that targeting therapeutic agents to limit it may be effective across multiple neurological disorders.
Collapse
Affiliation(s)
- Roeben Nocon Munji
- Departments of Pharmacology and Neurosciences, University of California, San Diego, San Diego, CA, USA
| | - Allison Luen Soung
- Departments of Pharmacology and Neurosciences, University of California, San Diego, San Diego, CA, USA
| | - Geoffrey Aaron Weiner
- Departments of Pharmacology and Neurosciences, University of California, San Diego, San Diego, CA, USA
| | - Fabien Sohet
- Departments of Pharmacology and Neurosciences, University of California, San Diego, San Diego, CA, USA
| | - Bridgette Deanne Semple
- Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA
| | - Alpa Trivedi
- Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA
| | - Kayleen Gimlin
- Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA
| | - Masakazu Kotoda
- Department of Neurosurgery and Neurobiology, Barrow Aneurysm and AVM Research Center, Barrow Neurological Institute, Phoenix, AZ, USA
| | - Masaaki Korai
- Department of Neurosurgery and Neurobiology, Barrow Aneurysm and AVM Research Center, Barrow Neurological Institute, Phoenix, AZ, USA
| | - Sidar Aydin
- Departments of Pharmacology and Neurosciences, University of California, San Diego, San Diego, CA, USA
| | - Austin Batugal
- Departments of Pharmacology and Neurosciences, University of California, San Diego, San Diego, CA, USA
| | | | - Patrick Georg Schupp
- Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA
| | - Michael Clark Oldham
- Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA
| | - Tomoki Hashimoto
- Department of Neurosurgery and Neurobiology, Barrow Aneurysm and AVM Research Center, Barrow Neurological Institute, Phoenix, AZ, USA
| | - Linda J Noble-Haeusslein
- Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA
| | - Richard Daneman
- Departments of Pharmacology and Neurosciences, University of California, San Diego, San Diego, CA, USA.
| |
Collapse
|
3
|
Nepal G, Yadav JK, Kong Y. Association between K469E polymorphism of ICAM‐1 gene and susceptibility of ischemic stroke: An updated meta‐analysis. Mol Genet Genomic Med 2019; 7:e00784. [PMID: 31157518 PMCID: PMC6625125 DOI: 10.1002/mgg3.784] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2019] [Revised: 05/08/2019] [Accepted: 05/17/2019] [Indexed: 12/03/2022] Open
Abstract
Background The intercellular adhesion molecule‐1 (ICAM‐1)/leukocyte function associated antigen‐1 (LFA‐1) adhesion system regulates leukocyte interactions, migration, and adhesion, and appears to play an important role in atherosclerosis and thrombosis. Therefore, single nucleotide polymorphisms (SNPs) of the ICAM‐1 gene may strongly influence the expression and biological activity of ICAM‐1 and play a potentially important role in the pathogenesis of ischemic stroke. In the current meta‐analysis, we investigated the relationship between the ICAM‐1 gene K469E SNP and the risk of ischemic stroke. Methods Two investigators independently searched PubMed, Web of Science, Google Scholar, WANFANG, China National Knowledge Infrastructure (CNKI) and J‐STAGE for studies published from January 2000 to February 2019 without language restriction. The association of K469E polymorphism and ischemic stroke in three genetic models (allelic, recessive, and dominant) were evaluated using Pooled odds ratios (ORs) with 95% confidence intervals (CIs). Results Our study included 20 studies from four continents and four different countries, including 3,137 cases and 15,382 controls. Meta‐analysis results did not show a significant association between K469E polymorphism of ICAM‐1 gene and ischemic stroke when assuming allelic model (OR: 1.12; 95% CI: 0.8 to 1.55; p = 0.51; I2 = 93%) or recessive model (OR: 1.28; 95% CI: 0.89 to 1.84; p = 0.18; I2 = 82%) or dominant model (OR: 1.20; 95% CI: 0.92 to 1.56; p = 0.17; I2 = 85%). However, in all three genetic models, subgroup analysis revealed that the K469E polymorphism of the ICAM‐1 gene is associated with ischemic stroke in the Caucasian population. Conclusion K469E polymorphism of ICAM‐1 gene might be a risk factor for ischemic stroke in Caucasians, which suggested that K469E polymorphism might help in early identification of those at risk and help in primary prevention of ischemic stroke.
Collapse
Affiliation(s)
- Gaurav Nepal
- Tribhuvan University Institute of Medicine Kathmandu Nepal
| | | | - YuHui Kong
- Chengdu University of Information Technology Chengdu Sichuan China
| |
Collapse
|
4
|
Bertrand L, Méroth F, Tournebize M, Leda AR, Sun E, Toborek M. Targeting the HIV-infected brain to improve ischemic stroke outcome. Nat Commun 2019; 10:2009. [PMID: 31043599 PMCID: PMC6494822 DOI: 10.1038/s41467-019-10046-x] [Citation(s) in RCA: 45] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2018] [Accepted: 04/12/2019] [Indexed: 12/13/2022] Open
Abstract
HIV-associated cerebrovascular events remain highly prevalent even in the current era of antiretroviral therapy (ART). We hypothesize that low-level HIV replication and associated inflammation endure despite antiretroviral treatment and affect ischemic stroke severity and outcomes. Using the EcoHIV infection model and the middle cerebral artery occlusion as the ischemic stroke model in mice, we present in vivo analysis of the relationship between HIV and stroke outcome. EcoHIV infection increases infarct size and negatively impacts tissue and functional recovery. Ischemic stroke also results in an increase in EcoHIV presence in the affected regions, suggesting post-stroke reactivation that magnifies pro-inflammatory status. Importantly, ART with a high CNS penetration effectiveness (CPE) is more beneficial than low CPE treatment in limiting tissue injury and accelerating post-stroke recovery. These results provide potential insight for treatment of HIV-infected patients that are at risk of developing cerebrovascular disease, such as ischemic stroke.
Collapse
Affiliation(s)
- Luc Bertrand
- University of Miami Miller School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL, 33136, USA.
| | - Fannie Méroth
- University of Miami Miller School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL, 33136, USA
| | - Marie Tournebize
- University of Miami Miller School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL, 33136, USA
| | - Ana Rachel Leda
- University of Miami Miller School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL, 33136, USA
| | - Enze Sun
- University of Miami Miller School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL, 33136, USA
| | - Michal Toborek
- University of Miami Miller School of Medicine, Department of Biochemistry and Molecular Biology, Miami, FL, 33136, USA.
| |
Collapse
|
5
|
Tahsili-Fahadan P, Farrokh S, Geocadin RG. Hypothermia and brain inflammation after cardiac arrest. Brain Circ 2018; 4:1-13. [PMID: 30276330 PMCID: PMC6057700 DOI: 10.4103/bc.bc_4_18] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Revised: 03/17/2018] [Accepted: 03/18/2018] [Indexed: 12/14/2022] Open
Abstract
The cessation (ischemia) and restoration (reperfusion) of cerebral blood flow after cardiac arrest (CA) induce inflammatory processes that can result in additional brain injury. Therapeutic hypothermia (TH) has been proven as a brain protective strategy after CA. In this article, the underlying pathophysiology of ischemia-reperfusion brain injury with emphasis on the role of inflammatory mechanisms is reviewed. Potential targets for immunomodulatory treatments and relevant effects of TH are also discussed. Further studies are needed to delineate the complex pathophysiology and interactions among different components of immune response after CA and identify appropriate targets for clinical investigations.
Collapse
Affiliation(s)
- Pouya Tahsili-Fahadan
- Department of Medicine, Virginia Commonwealth University, Falls Church, Virginia, USA.,Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Salia Farrokh
- Department of Pharmacy, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Romergryko G Geocadin
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.,Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| |
Collapse
|
6
|
Bajwa ZH, Smith SS, Khawaja SN, Scrivani SJ. Cranial Neuralgias. Oral Maxillofac Surg Clin North Am 2016; 28:351-70. [DOI: 10.1016/j.coms.2016.04.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|
7
|
Schmidt EP, Kuebler WM, Lee WL, Downey GP. Adhesion Molecules: Master Controllers of the Circulatory System. Compr Physiol 2016; 6:945-73. [PMID: 27065171 DOI: 10.1002/cphy.c150020] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
This manuscript will review our current understanding of cellular adhesion molecules (CAMs) relevant to the circulatory system, their physiological role in control of vascular homeostasis, innate and adaptive immune responses, and their importance in pathophysiological (disease) processes such as acute lung injury, atherosclerosis, and pulmonary hypertension. This is a complex and rapidly changing area of research that is incompletely understood. By design, we will begin with a brief overview of the structure and classification of the major groups of adhesion molecules and their physiological functions including cellular adhesion and signaling. The role of specific CAMs in the process of platelet aggregation and hemostasis and leukocyte adhesion and transendothelial migration will be reviewed as examples of the complex and cooperative interplay between CAMs during physiological and pathophysiological processes. The role of the endothelial glycocalyx and the glycobiology of this complex system related to inflammatory states such as sepsis will be reviewed. We will then focus on the role of adhesion molecules in the pathogenesis of specific disease processes involving the lungs and cardiovascular system. The potential of targeting adhesion molecules in the treatment of immune and inflammatory diseases will be highlighted in the relevant sections throughout the manuscript.
Collapse
Affiliation(s)
- Eric P Schmidt
- Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado, Aurora, Colorado, USA
| | - Wolfgang M Kuebler
- Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada
- Departments of Surgery and Physiology, University of Toronto, Toronto, Ontario, Canada
| | - Warren L Lee
- Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada
- Division of Respirology and the Interdepartmental Division of Critical Care Medicine, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Gregory P Downey
- Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado, Aurora, Colorado, USA
- Division of Pulmonary, Critical Care, and Sleep Medicine, Departments of Medicine, Pediatrics, and Biomedical Research, National Jewish Health, Denver, Colorado, USA
- Departments of Medicine, and Immunology and Microbiology, University of Colorado, Aurora, Colorado, USA
| |
Collapse
|
8
|
Burfeind KG, Michaelis KA, Marks DL. The central role of hypothalamic inflammation in the acute illness response and cachexia. Semin Cell Dev Biol 2015; 54:42-52. [PMID: 26541482 DOI: 10.1016/j.semcdb.2015.10.038] [Citation(s) in RCA: 101] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2015] [Accepted: 10/26/2015] [Indexed: 12/19/2022]
Abstract
When challenged with a variety of inflammatory threats, multiple systems across the body undergo physiological responses to promote defense and survival. The constellation of fever, anorexia, and fatigue is known as the acute illness response, and represents an adaptive behavioral and physiological reaction to stimuli such as infection. On the other end of the spectrum, cachexia is a deadly and clinically challenging syndrome involving anorexia, fatigue, and muscle wasting. Both of these processes are governed by inflammatory mediators including cytokines, chemokines, and immune cells. Though the effects of cachexia can be partially explained by direct effects of disease processes on wasting tissues, a growing body of evidence shows the central nervous system (CNS) also plays an essential mechanistic role in cachexia. In the context of inflammatory stress, the hypothalamus integrates signals from peripheral systems, which it translates into neuroendocrine perturbations, altered neuronal signaling, and global metabolic derangements. Therefore, we will discuss how hypothalamic inflammation is an essential driver of both the acute illness response and cachexia, and why this organ is uniquely equipped to generate and maintain chronic inflammation. First, we will focus on the role of the hypothalamus in acute responses to dietary and infectious stimuli. Next, we will discuss the role of cytokines in driving homeostatic disequilibrium, resulting in muscle wasting, anorexia, and weight loss. Finally, we will address mechanisms and mediators of chronic hypothalamic inflammation, including endothelial cells, chemokines, and peripheral leukocytes.
Collapse
Affiliation(s)
- Kevin G Burfeind
- Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA
- MD/PhD Program, Oregon Health & Science University, Portland, OR, USA
| | - Katherine A Michaelis
- Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA
- MD/PhD Program, Oregon Health & Science University, Portland, OR, USA
| | - Daniel L Marks
- Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA
| |
Collapse
|
9
|
Seventy-two hours of mild hypothermia after cardiac arrest is associated with a lowered inflammatory response during rewarming in a prospective observational study. CRITICAL CARE : THE OFFICIAL JOURNAL OF THE CRITICAL CARE FORUM 2014; 18:546. [PMID: 25304549 PMCID: PMC4209077 DOI: 10.1186/s13054-014-0546-5] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/19/2014] [Accepted: 09/16/2014] [Indexed: 12/16/2022]
Abstract
INTRODUCTION Whole-body ischemia and reperfusion trigger a systemic inflammatory response. In this study, we analyzed the effect of temperature on the inflammatory response in patients treated with prolonged mild hypothermia after cardiac arrest. METHODS Ten comatose patients with return of spontaneous circulation after pulseless electrical activity/asystole or prolonged ventricular fibrillation were treated with mild therapeutic hypothermia for 72 hours after admission to a tertiary care university hospital. At admission and at 12, 24, 36, 48, 72, 96 and 114 hours, the patients' temperature was measured and blood samples were taken from the arterial catheter. Proinflammatory interleukin 6 (IL-6) and anti-inflammatory (IL-10) cytokines and chemokines (IL-8 and monocyte chemotactic protein 1), intercellular adhesion molecule 1 and complement activation products (C1r-C1s-C1inhibitor, C4bc, C3bPBb, C3bc and terminal complement complex) were measured. Changes over time were analyzed with the repeated measures test for nonparametric data. Dunn's multiple comparisons test was used for comparison of individual time points. RESULTS The median temperature at the start of the study was 34.3°C (33.4°C to 35.2°C) and was maintained between 32°C and 34°C for 72 hours. All patients were passively rewarmed after 72 hours, from (median (IQR)) 33.7°C (33.1°C to 33.9°C) at 72 hours to 38.0°C (37.5°C to 38.1°C) at 114 hours (P <0.001). In general, the cytokines and chemokines remained stable during hypothermia and decreased during rewarming, whereas complement activation was suppressed during the whole hypothermia period and increased modestly during rewarming. CONCLUSIONS Prolonged hypothermia may blunt the inflammatory response after rewarming in patients after cardiac arrest. Complement activation was low during the whole hypothermia period, indicating that complement activation is also highly temperature-sensitive in vivo. Because inflammation is a strong mediator of secondary brain injury, a blunted proinflammatory response after rewarming may be beneficial.
Collapse
|
10
|
Abstract
Reperfusion of ischemic brain can reduce injury and improve outcome, but secondary injury due to inflammatory mechanisms limits the efficacy and time window of such treatments for stroke. This review summarizes the cellular and molecular basis of inflammation in ischemic injury as well as possible therapeutic strategies.
Collapse
Affiliation(s)
- Muzamil Ahmad
- Geriatric Research Educational and Clinical Center (00-GR-H), V.A. Pittsburgh Healthcare System, 7180 Highland Drive, Pittsburgh, PA 15206, USA; Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA
| | | |
Collapse
|
11
|
Angiari S, Constantin G. Selectins and their ligands as potential immunotherapeutic targets in neurological diseases. Immunotherapy 2013; 5:1207-20. [DOI: 10.2217/imt.13.122] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
Selectins are a family of adhesion receptors that bind to highly glycosylated molecules expressed on the surface of leukocytes and endothelial cells. The interactions between selectins and their ligands control tethering and rolling of leukocytes on the vascular wall during the process of leukocyte migration into the tissues under physiological and pathological conditions. In recent years, it has been shown that leukocyte recruitment in the CNS plays a pivotal role in diseases such as multiple sclerosis, ischemic stroke, epilepsy and traumatic brain injury. In this review, we discuss the role of selectins in leukocyte–endothelial interactions in the pathogenesis of neurological diseases, highlighting new findings suggesting that selectins and their ligands may represent novel potential therapeutic targets for the treatment of CNS diseases.
Collapse
Affiliation(s)
- Stefano Angiari
- Department of Pathology & Diagnostics, Section of General Pathology, University of Verona, Strada le Grazie 8, Verona 37134, Italy
| | - Gabriela Constantin
- Department of Pathology & Diagnostics, Section of General Pathology, University of Verona, Strada le Grazie 8, Verona 37134, Italy
| |
Collapse
|
12
|
Daneman R. The blood-brain barrier in health and disease. Ann Neurol 2012; 72:648-72. [DOI: 10.1002/ana.23648] [Citation(s) in RCA: 482] [Impact Index Per Article: 37.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2011] [Revised: 05/02/2012] [Accepted: 05/04/2012] [Indexed: 12/12/2022]
|
13
|
Schneider A, Albertsmeier M, Böttiger BW, Teschendorf P. [Post-resuscitation syndrome. Role of inflammation after cardiac arrest]. Anaesthesist 2012; 61:424-36. [PMID: 22576987 DOI: 10.1007/s00101-012-2002-8] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Cardiac arrest with subsequent cardiopulmonary resuscitation causes an ischemic reperfusion syndrome of the whole body resulting in localized damage of particularly sensitive organs, such as the brain and heart, together with systemic sequelae. The main factor is a generalized activation of inflammatory reactions resulting in symptoms similar in many aspects to those of sepsis. Systemic inflammation strengthens organ damage due to disorders in the macrocirculation and microcirculation due to metabolic imbalance as well as the effects of direct leukocyte transmitted tissue destruction. The current article gives an overview on the role of inflammation following cardiac arrest and presents in detail the underlying mechanisms, the clinical symptoms and possible therapeutic approaches.
Collapse
Affiliation(s)
- A Schneider
- Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Köln, Kerpener Str. 62, 50937 Köln, Deutschland.
| | | | | | | |
Collapse
|
14
|
Abstract
White blood cell infiltration across an activated brain endothelium contributes to neurologic disease, including cerebral ischemia and multiple sclerosis. Identifying mechanisms of cerebrovascular activation is therefore critical to our understanding of brain disease. Platelet accumulation in microvessels of ischemic mouse brain was associated with endothelial activation in vivo. Mouse platelets expressed interleukin-1alpha (IL-1alpha), but not IL-1beta, induced endothelial cell adhesion molecule expression (ICAM-1 and VCAM-1), and enhanced the release of CXC chemokine CXCL1 when incubated with primary cultures of brain endothelial cells from wild-type or IL-1alpha/beta-deficient mice. A neutralizing antibody to IL-1alpha (but not IL-1beta) or application of IL-1 receptor antagonist inhibited platelet-induced endothelial activation by more than 90%. Platelets from IL-1alpha/beta-deficient mice did not induce expression of adhesion molecules in cerebrovascular endothelial cells and did not promote CXCL1 release in vitro. Conditioned medium from activated platelets induced an IL-1alpha-dependent activation of mouse brain endothelial cells and supported the transendothelial migration of neutrophils in vitro. Thus, we have identified platelets as a key source of IL-1alpha and propose that platelet activation of brain endothelium via IL-1alpha is a critical step for the entry of white blood cells, major contributors to inflammation-mediated injury in the brain.
Collapse
|
15
|
Abstract
Stroke is the major cause of disability in the Western world and is the third greatest cause of death, but there are no widely effective treatments to prevent the devastating effects of stroke. Extensive and growing evidence implicates inflammatory and immune processes in the occurrence of stroke and particularly in the subsequent injury. Several inflammatory mediators have been identified in the pathogenesis of stroke including specific cytokines, adhesion molecules, matrix metalloproteinases, and eicosanoids. An early clinical trial suggests that inhibiting interleukin-1 may be of benefit in the treatment of acute stroke.
Collapse
|
16
|
|
17
|
Ovechkin AV, Lominadze D, Sedoris KC, Robinson TW, Tyagi SC, Roberts AM. Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem 2007; 113:1-12. [PMID: 17522980 PMCID: PMC3182489 DOI: 10.1080/13813450601118976] [Citation(s) in RCA: 85] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Pulmonary ischemia-reperfusion (IR) injury may result from trauma, atherosclerosis, pulmonary embolism, pulmonary thrombosis and surgical procedures such as cardiopulmonary bypass and lung transplantation. IR injury induces oxidative stress characterized by formation of reactive oxygen (ROS) and reactive nitrogen species (RNS). Nitric oxide (NO) overproduction via inducible nitric oxide synthase (iNOS) is an important component in the pathogenesis of IR. Reaction of NO with ROS forms RNS as secondary reactive products, which cause platelet activation and upregulation of adhesion molecules. This mechanism of injury is particularly important during pulmonary IR with increased iNOS activity in the presence of oxidative stress. Platelet-endothelial interactions may play an important role in causing pulmonary arteriolar vasoconstriction and post-ischemic alveolar hypoperfusion. This review discusses the relationship between ROS, RNS, P-selectin, and platelet-arteriolar wall interactions and proposes a hypothesis for their role in microvascular responses during pulmonary IR.
Collapse
Affiliation(s)
- Alexander V Ovechkin
- Department of Physiology, School of Medicine University of Louisville, Louisville, Kentucky 40202, USA.
| | | | | | | | | | | |
Collapse
|
18
|
Abstract
There is now considerable evidence from both experimental and clinical studies that immune and inflammatory processes can contribute to the onset of stroke and the neurologic and psychologic outcomes. Several specific therapeutic targets have been identified that may significantly improve the devastating impact of stroke.
Collapse
Affiliation(s)
- Robert Skinner
- Faculty of Life Sciences, Michael Smith Building (C2210), University of Manchester, Acker Street, Manchester M13 9PT, UK.
| | | | | | | |
Collapse
|
19
|
Littleton-Kearney MT, Gaines JM, Callahan KP, Murphy SJ, Hurn PD. Effects of estrogen on platelet reactivity after transient forebrain ischemia in rats. Biol Res Nurs 2005; 7:135-45. [PMID: 16267375 PMCID: PMC2678714 DOI: 10.1177/1099800405276832] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Estrogen's prothrombotic effects are of increasing concern, particularly in stroke risk and recovery. Using an ischemic rodent model, the authors sought to determine (a) if estrogen replacement increases postischemic platelet reactivity, (b) if changes in estrogen status alter intraplatelet endothelial nitric oxide synthase (eNOS) synthesis, and (c) if estrogen-mediated effects on platelets alter cerebral blood flow during reperfusion. Intact (I), ovariectomized (OVX), and OVX + 17 beta-estradiol (E50) rats were subjected to 30 min of forebrain ischemia and 60 min of reperfusion. Using the platelet activation marker P-selectin, postischemic platelet reactivity was quantified by flow cytometry. In a separate cohort (I, OVX, E50), the authors quantified platelet eNOS by Western blot. Another cohort (OVX, E50) was subjected to ischemia/reperfusion, and cerebral blood flow was determined using the iodoantipyrine technique. Collagen-stimulated platelet P-selectin expression was increased in the OVX rats at 60 min of reperfusion, and this effect was reversed by estrogen treatment. No differences in platelet eNOS expression were detected among groups. Cerebral blood flow at 60 min reperfusion was comparable between the OVX and the E50 rats. The authors conclude that during reper-fusion, estrogen deficiency increases postischemic platelet sensitivity to stimuli in estrogen-deficient rats. Estrogen treatment mitigates effects of estrogen loss on platelets, but this early effect is apparently not caused by intraplatelet eNOS depression. Neither estrogen deficiency nor estrogen treatment changes early postischemic regional brain blood flow. In this rodent global cerebral ischemic model, physiologic doses of estrogen are not deleterious to platelet reactivity and may initially reduce postischemic platelet reactivity.
Collapse
|
20
|
Piccio L, Rossi B, Colantonio L, Grenningloh R, Gho A, Ottoboni L, Homeister JW, Scarpini E, Martinello M, Laudanna C, D'Ambrosio D, Lowe JB, Constantin G. Efficient Recruitment of Lymphocytes in Inflamed Brain Venules Requires Expression of Cutaneous Lymphocyte Antigen and Fucosyltransferase-VII. THE JOURNAL OF IMMUNOLOGY 2005; 174:5805-13. [PMID: 15843584 DOI: 10.4049/jimmunol.174.9.5805] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Lymphocyte migration into the brain represents a critical event in the pathogenesis of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). However, the mechanisms controlling the recruitment of lymphocytes to the CNS via inflamed brain venules are poorly understood, and therapeutic approaches to inhibit this process are consequently few. In this study, we demonstrate for the first time that human and murine Th1 lymphocytes preferentially adhere to murine inflamed brain venules in an experimental model that mimics early inflammation during EAE. A virtually complete inhibition of rolling and arrest of Th1 cells in inflamed brain venules was observed with a blocking anti-P-selectin glycoprotein ligand 1 Ab and anti-E- and P-selectin Abs. Th1 lymphocytes produced from fucosyltransferase (FucT)-IV(-/-) mice efficiently tethered and rolled, whereas in contrast, primary adhesion of Th1 lymphocytes obtained from FucT-VII(-/-) or Fuc-VII(-/-)FucT-IV(-/-) mice was drastically reduced, indicating that FucT-VII is critical for the recruitment of Th1 cells in inflamed brain microcirculation. Importantly, we show that Abs directed against cutaneous lymphocyte Ag (CLA), a FucT-VII-dependent carbohydrate modification of P-selectin glycoprotein ligand 1, blocked rolling of Th1 cells. By exploiting a system that allowed us to obtain Th1 and Th2 cells with skin- vs gut-homing (CLA(+) vs integrin beta(7)(+)) phenotypes, we observed that induced expression of CLA on Th cells determined a striking increase of rolling efficiency in inflamed brain venules. These observations allow us to conclude that efficient recruitment of activated lymphocytes to the brain in the contexts mimicking EAE is controlled by FucT-VII and its cognate cell surface Ag CLA.
Collapse
MESH Headings
- Adjuvants, Immunologic/biosynthesis
- Adjuvants, Immunologic/physiology
- Animals
- Antigens, Differentiation, T-Lymphocyte
- Antigens, Neoplasm
- Brain/blood supply
- Brain/enzymology
- Brain/pathology
- Cell Communication/genetics
- Cell Communication/immunology
- Cell Movement/genetics
- Cell Movement/immunology
- Cells, Cultured
- E-Selectin/physiology
- Encephalomyelitis, Autoimmune, Experimental/enzymology
- Encephalomyelitis, Autoimmune, Experimental/genetics
- Encephalomyelitis, Autoimmune, Experimental/immunology
- Encephalomyelitis, Autoimmune, Experimental/pathology
- Endothelium, Vascular/immunology
- Endothelium, Vascular/metabolism
- Endothelium, Vascular/pathology
- Female
- Fucosyltransferases/biosynthesis
- Fucosyltransferases/deficiency
- Fucosyltransferases/genetics
- Humans
- Membrane Glycoproteins/biosynthesis
- Membrane Glycoproteins/physiology
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- P-Selectin/physiology
- Th1 Cells/immunology
- Th1 Cells/metabolism
- Th1 Cells/pathology
- Venules/enzymology
- Venules/immunology
- Venules/pathology
Collapse
Affiliation(s)
- Laura Piccio
- Department of Pathology, University of Verona, Verona, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Dirnagl U. Inflammation in stroke: the good, the bad, and the unknown. ERNST SCHERING RESEARCH FOUNDATION WORKSHOP 2004:87-99. [PMID: 15032055 DOI: 10.1007/978-3-662-05426-0_5] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- U Dirnagl
- Abteilung Experimentelle Neurologie, Charité, Humboldt University, Schumannstrasse 20/21, 10098 Berlin, Germany.
| |
Collapse
|
22
|
Abstract
The death of neurons after brain ischaemia may be associated with activation of cyclin-dependent kinases (CDKs) and upregulation of cyclins, reflecting aberrant entry of neurons into the cell cycle. Little has been published on the expression of cell cycle proteins after brain ischaemia in man. Well-characterized antisera were therefore used to examine the neuronal expression of CDK2, CDK4 and cyclins A, D1 and E in sections of brain from patients who had experienced cardiac arrest or focal brain infarction, and died 3.5 h to 9 days later. Scattered neurons contained elevated levels of cyclin D1, CDK2 and, to a lesser extent, CDK4, but little or no cyclin A or E. Present findings indicate that brain ischaemia induces the entry of some neurons from G0 into the G1 phase of the cell cycle, and suggest a potential therapeutic role for CDK inhibitors in ischaemic stroke.
Collapse
Affiliation(s)
- Seth Love
- Department of Neuropathology, Institute of Clinical Neurosciences, Frenchay Hospital, Bristol BS16 1LE, UK.
| |
Collapse
|
23
|
Shi L, Tian FZ, Huang DR, Li X, Zhao B, Gu DY, Tang XD, Wang Y. Effect of hepatic NF-κB on ICAM-1 expression in rats with acute pancreatitis. Shijie Huaren Xiaohua Zazhi 2003; 11:1505-1507. [DOI: 10.11569/wcjd.v11.i10.1505] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM To study the effect of hepatic NF-κB on ICAM-1 expression in rats with acute pancreatitis.
METHODS Seventy-two Wistar rats were randomly divided into three groups: acute pancreatitis group (AP), acute pancreatitis treated with pyrrolidine dithiocarbamate(PDTC) group (APP) and sham operation group (SO). Hepatic NF-κB activities were determined with EMSA. The expression of hepatic ICAM-1 was detected with immunohistochemistry. Hepatic myeloperoxidase (MPO) and serum alanine aminotransferase (ALT) were measured.
RESULTS Activities of NF-κB were significantly higher in AP and APP groups than that in SO group from 3 to 6 hours. The expressions of ICAM-1 were stronger in AP and APP groups than in SO group. The levels of hepatic MPO and serum ALT were also significantly higher in these two groups than in SO group. However, compared with AP group, the activities of NF-κB, the expression of ICAM-1 and the level of hepatic MPO and ALT significantly decreased in APP group.
CONCLUSION Activation of hepatic NF-κB is involved in the liver injury by regulating ICAM-1 expression during pancreatitis.
Collapse
Affiliation(s)
- Li Shi
- Center of General Surgery, General Hospital of Chinese PLA Chengdu Command, Chengdu 610083, SiChuan Province, China
| | - Fu-Zhou Tian
- Center of General Surgery, General Hospital of Chinese PLA Chengdu Command, Chengdu 610083, SiChuan Province, China
| | - Da-Rong Huang
- Center of General Surgery, General Hospital of Chinese PLA Chengdu Command, Chengdu 610083, SiChuan Province, China
| | - Xu Li
- Center of General Surgery, General Hospital of Chinese PLA Chengdu Command, Chengdu 610083, SiChuan Province, China
| | - Bi Zhao
- Hematologic Department, General Hospital of Chinese PLA Chengdu Command, Chengdu 610083, SiChuan Province, China
| | - Da-Yong Gu
- Center of General Surgery, General Hospital of Chinese PLA Chengdu Command, Chengdu 610083, SiChuan Province, China
| | - Xu-Dong Tang
- Center of General Surgery, General Hospital of Chinese PLA Chengdu Command, Chengdu 610083, SiChuan Province, China
| | - Yu Wang
- Center of General Surgery, General Hospital of Chinese PLA Chengdu Command, Chengdu 610083, SiChuan Province, China
| |
Collapse
|
24
|
Kivisäkk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T, Wu L, Baekkevold ES, Lassmann H, Staugaitis SM, Campbell JJ, Ransohoff RM. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci U S A 2003; 100:8389-94. [PMID: 12829791 PMCID: PMC166239 DOI: 10.1073/pnas.1433000100] [Citation(s) in RCA: 419] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
Cerebrospinal fluid (CSF) from healthy individuals contains between 1,000 and 3,000 leukocytes per ml. Little is known about trafficking patterns of leukocytes between the systemic circulation and the noninflamed CNS. In the current study, we characterized the surface phenotype of CSF cells and defined the expression of selected adhesion molecules on vasculature in the choroid plexus, the subarachnoid space surrounding the cerebral cortex, and the cerebral parenchyma. Using multicolor flow cytometry, we found that CSF cells predominantly consisted of CD4+/CD45RA-/CD27+/CD69+-activated central memory T cells expressing high levels of CCR7 and L-selectin. CD3+ T cells were present in the choroid plexus stroma in autopsy CNS tissue sections from individuals who died without known neurological disorders. P- and E-selectin immunoreactivity was detected in large venules in the choroid plexus and subarachnoid space, but not in parenchymal microvessels. CD4+ T cells in the CSF expressed high levels of P-selectin glycoprotein ligand 1, and a subpopulation of circulating CD4+ T cells displayed P-selectin binding activity. Intercellular adhesion molecule 1, but not vascular cell adhesion molecule 1 or mucosal addressin cell adhesion molecule 1, was expressed in choroid plexus and subarachnoid space vessels. Based on these findings, we propose that T cells are recruited to the CSF through interactions between P-selectin/P-selectin ligands and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 in choroid plexus and subarachnoid space venules. These results support the overall hypothesis that activated memory T cells enter CSF directly from the systemic circulation and monitor the subarachnoid space, retaining the capacity to either initiate local immune reactions or return to secondary lymphoid organs.
Collapse
Affiliation(s)
- Pia Kivisäkk
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - Don J. Mahad
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - Melissa K. Callahan
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - Corinna Trebst
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - Barbara Tucky
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - Tao Wei
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - Lijun Wu
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - Espen S. Baekkevold
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - Hans Lassmann
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - Susan M. Staugaitis
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - James J. Campbell
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
| | - Richard M. Ransohoff
- Department of Neurosciences, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, OH 44195;
Millennium Pharmaceuticals, Inc., Cambridge,
MA 02142; Joint Program in Transfusion
Medicine, Children's Hospital, Boston, MA 02115;
Laboratory of Immunohistochemistry and
Immunopathology, Institute of Pathology, University of Oslo, Rikshospitalet,
0027 Oslo, Norway; Brain Research Institute,
University of Vienna, A-1090 Vienna, Austria; and
Department of Pathology, Harvard Medical School,
Boston, MA 02115
- To whom correspondence should be addressed. E-mail:
| |
Collapse
|
25
|
Tan KT, Lip GYH, Blann AD. Post-stroke inflammatory response: effects of stroke evolution and outcome. Curr Atheroscler Rep 2003; 5:245-51. [PMID: 12793964 DOI: 10.1007/s11883-003-0046-6] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Recovery after stroke is often hindered by further neurologic deterioration, which can affect up to 45% of patients. It has been suggested that one of the major causes of this neurologic deterioration may be post-ischemic cerebral inflammation. This review presents the basis of pathophysiologic mechanisms of post-stroke inflammation and discusses possible targets and routes for therapeutic intervention.
Collapse
Affiliation(s)
- Kiat T Tan
- Haemostasis, Thrombosis, and Vascular Biology Unit, University Department of Medicine, City Hospital, Dudley Road, Birmingham B18 7QH, UK
| | | | | |
Collapse
|
26
|
|
27
|
Laudanna C, Constantin G. New models of intravital microscopy for analysis of chemokine receptor-mediated leukocyte vascular recognition. J Immunol Methods 2003; 273:115-23. [PMID: 12535802 DOI: 10.1016/s0022-1759(02)00421-0] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
Chemokines control selective targeting of circulating leukocytes to the microvasculature by triggering inside-out signal transduction pathways leading to integrin-dependent adhesion. Presently, a few examples of presentation of chemokines by the inner surface of blood vessels responsible for triggering leukocyte arrest are available. A complete pattern of chemokine expression and presentation by the endothelium in different tissues and in homeostatic versus inflammatory conditions is still lacking. This review describes a novel intravital microscopy model allowing visualization of cerebral vessels through the skull, and analysis of the interactions between different leukocyte subpopulations and the endothelium in brain superficial microvasculature of mice. It has been recently shown that inflamed brain endothelium expresses a combination of adhesion ligands and activating factor(s) for G(i)-linked receptors that together mediate lymphocyte recruitment, and that the combination of molecules involved in this central nervous system (CNS) venule adhesion cascade strongly favors the arrest of activated versus nai;ve T cells. However, the identification of the chemokine(s) expressed by the endothelium leading to integrin activation and arrest still remains to be determined. The new approach presented here to study the brain microcirculation may provide an useful tool for further investigations of physiologic and pathologic events that occur in the CNS.
Collapse
Affiliation(s)
- Carlo Laudanna
- Section of General Pathology, Department of Pathology, University of Verona, Strade le Grazie 8, Verona 37134, Italy
| | | |
Collapse
|
28
|
Abstract
Inflammation has been implicated as a secondary injury mechanism following ischemia and stroke. A variety of experimental models, including thromboembolic stroke, focal and global ischemia, have been used to evaluate the importance of inflammation. The vasculature endothelium promotes inflammation through the upregulation of adhesion molecules such as ICAM, E-selectin, and P-selectin that bind to circulating leukocytes and facilitate their migration into the CNS. Once in the CNS, the production of cytotoxic molecules may facilitate cell death. The macrophage and microglial response to injury may either be beneficial by scavenging necrotic debris or detrimental by facilitating cell death in neurons that would otherwise recover. While many studies have tested these hypotheses, the importance of inflammation in these models is inconclusive. This review summarizes data regarding the role of the vasculature, leukocytes, blood-brain barrier, macrophages, and microglia after experimental and clinical stroke.
Collapse
Affiliation(s)
- Gary H Danton
- Department of Neurological Surgery, The Miami Project to Cure Paralysis, University of Miami School of Medicine, Miami, Florida 33101, USA
| | | |
Collapse
|
29
|
Ohtaki H, Endo S, Nakamachi T, Yin L, Dohi K, Kudo Y, Iwai Y, Matsunaga M, Goto N, Shioda S. Increased Expression of Intercellular Adhesion Molecule-1 (ICAM-1) in Mouse Brain Following Transient Cerebral Ischemia. Acta Histochem Cytochem 2003. [DOI: 10.1267/ahc.36.385] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Affiliation(s)
- Hirokazu Ohtaki
- Department of Anatomy, Showa University School of Medicine
- The Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology (JST)
| | - Sakura Endo
- Department of Anatomy, Showa University School of Medicine
| | | | - Li Yin
- Department of Anatomy, Showa University School of Medicine
| | - Kenji Dohi
- Emergency and Clinical Care Medicine, Showa University School of Medicine
| | - Yoshifumi Kudo
- Department of Anatomy, Showa University School of Medicine
| | - Yumiko Iwai
- Department of Anatomy, Showa University School of Medicine
| | | | - Noboru Goto
- Department of Anatomy, Showa University School of Medicine
| | - Seiji Shioda
- Department of Anatomy, Showa University School of Medicine
- The Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology (JST)
| |
Collapse
|